Jade Biosciences
JBIO
78 hedge funds and large institutions have $79.6M invested in Jade Biosciences in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 9 closing their positions.
37% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 19
0.14% more ownership
Funds ownership: 2.98% → 3.12% (+0.14%)
0% more funds holding
Funds holding: 78 → 78 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
0% less capital invested
Capital invested by funds: $79.9M → $79.6M (-$382K)
52% less call options, than puts
Call options by funds: $76K | Put options by funds: $159K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCC
Cable Car Capital
San Francisco,
California
|
+$1.48M |
| 2 |
AI
Allostery Investments
Stamford,
Connecticut
|
+$1.43M |
| 3 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$1.34M |
| 4 |
Blackstone Inc
New York
|
+$1.14M |
| 5 |
DAM
Deltec Asset Management
New York
|
+$421K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$1.28M |
| 2 |
PCM
Prelude Capital Management
New York
|
-$290K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$258K |
| 4 |
Morgan Stanley
New York
|
-$219K |
| 5 |
VAM
Vazirani Asset Management
New York
|
-$199K |
JBIO Hedge Fund Activity: Q1 2025 in Review
78 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in Jade Biosciences (JBIO) for Q1 2025, worth a combined $79.6M — down 0.48% from $79.9M a quarter earlier.
Fund positioning in JBIO was balanced in Q1 2025: 9 funds opened new positions, 9 closed out, 26 added to existing stakes and 19 trimmed.
The largest buyer was Cable Car Capital, opening a new position worth an estimated $1.48M. The largest seller was Nantahala Capital Management, exiting entirely with an estimated $1.28M sold.
- 78 institutional investors held Jade Biosciences (JBIO) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $79.6M of Jade Biosciences stock for Q1 2025, down 0.48% quarter-over-quarter.
- 9 funds opened new Jade Biosciences positions in Q1 2025 and 9 closed out, a net change of 0 holders.
- The largest Jade Biosciences buyer in Q1 2025 was Cable Car Capital, an estimated $1.48M added.
- The largest Jade Biosciences seller in Q1 2025 was Nantahala Capital Management, an estimated $1.28M sold.
Based on aggregated 13F filings for Q1 2025.